Eli Lilly and Company v. Human Genome Sciences, Court of Appeal, London, UK, 5 September 2012, with thanks to Penny Gilbert, Powell Gilbert, for sending in the case
"This follows on from the Supreme Court's finding that the HGS patent had industrial application, leaving the Court of Appeal to review issues on the law of sufficiency in relation to antibody claims and an issue of extension of protection. The HGS appeal succeeded, and Lilly's Appeal was dismissed, so that all claims of the HGS patent were held valid."
Read the decision (in English) here.
[Further head note follows]